PEN is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 34.5% year-over-year for the current fiscal year, with sales growth of 12.5%.

Over the past decade, peptide therapy has gained traction for its ability to stimulate growth hormone production naturally. These peptides work synergistically to stimulate the pituitary gland ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally ...